Croda International Plc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Croda International Plc with three other
pharmaceutical manufacturers in Europe:
Krka DD Novo Mesto
sales of 1.49 billion Euros [US$1.81 billion]
of which 59%
was European Union),
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
(507.79 billion Hungarian Forints [US$1.71 billion]
of which 78%
was Pharmaceutical Manufacturing and Sale), and
Recordati Industria Chimica e Farmaceutica SpA
based in ITALY
(1.48 billion Euros [US$1.79 billion]
of which 83%
was Specialty & Primary care).
Croda International Plc reported sales of £1.38 billion (US$1.87 billion)
December of 2019.
decrease of 0.7%
versus 2018, when the company's sales were £1.39 billion.
Contributing to the drop in overall sales was the 5.7% decline
in Performance Technologies, from £456.40 million to £430.20 million.
There were also decreases in sales in
Personal Care (down 0.5% to £485.20 million)
Industrial Chemicals (down 5.4% to £111.80 million)
However, these declines were partially offset by the increase in sales of
Life Sciences (up 8.0% to £350.50 million)